VITOC VLAD (Chief Executive Officer) purchased 8.9% of their position (72K shares) of MAIA BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $79.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/1/2025ACC: 0001878313-25-000056
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2022
+72K
Net shares
Net buyer
$79.8K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
72K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+22K
Price / share
$1.05
Trade value
$23.02K
% of position
2.6%
11/26/2025
831.42K→853.42K
Common Stock
Direct
Shares
+50K
Price / share
$1.14
Trade value
$56.83K
% of position
6.0%
11/28/2025
831.42K→881.42K
Total
Net shares
+72K
Net value
$79.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/26/2025 | P · Purchase | +22K | $1.05 | $23.02K | 2.6% | 831.42K | 853.42K |
| Common Stock Direct | 11/28/2025 | P · Purchase | +50K | $1.14 | $56.83K | 6.0% | 831.42K | 881.42K |
| Total | +72K | $79.85K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned210K
Total
210K indirect210K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 210K | Indirect |
| Total | 210K | 210K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported